BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 34264155)

  • 1. Elevated Serum Immunoglobulin E Levels are Associated with the Severity of Newly Diagnosed, Acute Vogt-Koyanagi-Harada Disease.
    Ji H; Zhang N; Zhu M; Dong J; Jiang Z
    Curr Eye Res; 2022 Jan; 47(1):102-106. PubMed ID: 34264155
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Changes in Central Macular Thickness and Retinal Nerve Fiber Layer Thickness in Eyes with Vogt-Koyanagi-Harada Disease: A 2-Year Follow-Up Study.
    Han YS; Shin KS; Lee WH; Kim JY
    Ophthalmologica; 2018; 239(2-3):143-150. PubMed ID: 29339644
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlation between serum immunoglobulin levels and retinal structure in patients with newly diagnosed Vogt‑Koyanagi‑Harada disease.
    Jiang Z; Zhang N; Ji H; Zhu M; Zhou M; Dong J
    Mol Med Rep; 2022 Sep; 26(3):. PubMed ID: 35904174
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recovery of macular cone photoreceptors in Vogt-Koyanagi-Harada disease.
    Nakamura T; Hayashi A; Oiwake T
    Graefes Arch Clin Exp Ophthalmol; 2018 Feb; 256(2):387-394. PubMed ID: 29264653
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of macular capillary perfusion in patients with inactive Vogt-Koyanagi-Harada disease: an optical coherence tomography angiography study.
    Karaca I; Yılmaz SG; Afrashi F; Nalçacı S
    Graefes Arch Clin Exp Ophthalmol; 2020 Jun; 258(6):1181-1190. PubMed ID: 32363500
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Longitudinal observation of subretinal fibrosis in Vogt-Koyanagi-Harada disease.
    Zhao C; Dong F; Gao F; Liu X; Pei M; Jia S; Zhang M
    BMC Ophthalmol; 2018 Jan; 18(1):6. PubMed ID: 29334924
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multispectral image analysis in Vogt-Koyanagi-Harada disease.
    Huang G; Peng J; Ye Z; Kijlstra A; Zhang D; Yang P
    Acta Ophthalmol; 2018 Jun; 96(4):411-419. PubMed ID: 29220112
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Optical coherence tomographic assessment of dynamic macular changes in patients with Vogt-Koyanagi-Harada disease.
    Ikewaki J; Kimoto K; Choshi T; Nagata M; Motomura Y; Tamura K; Shinoda K; Nakatsuka K
    Int Ophthalmol; 2011 Feb; 31(1):9-13. PubMed ID: 21194005
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Retinal Pigment Epithelium Detachment in Acute Vogt-Koyanagi-Harada Disease: An Unusual Finding at Presentation.
    Khochtali S; Ksiaa I; Megzari K; Khairallah M
    Ocul Immunol Inflamm; 2019; 27(4):591-594. PubMed ID: 29513616
    [No Abstract]   [Full Text] [Related]  

  • 10. A case of probable Vogt-Koyanagi-Harada disease in a 3-year-old girl.
    Katsuyama A; Kusuhara S; Awano H; Nagase H; Matsumiya W; Nakamura M
    BMC Ophthalmol; 2019 Aug; 19(1):179. PubMed ID: 31409322
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SS OCT and OCT-A Findings in Convalescent Inactive Vogt-Koyanagi-Harada Disease.
    Ben Aoun S; Ksiaa I; Nefzi D; Khochtali S; Jelliti B; Abroug N; Khairallah M
    Ocul Immunol Inflamm; 2024 May; 32(4):407-414. PubMed ID: 37948509
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of the optical coherence tomographic characters between acute Vogt-Koyanagi-Harada disease and acute central serous chorioretinopathy.
    Lin D; Chen W; Zhang G; Huang H; Zhou Z; Cen L; Chen H
    BMC Ophthalmol; 2014 Jun; 14():87. PubMed ID: 24974016
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical relevance of fibrin membranous structures in the intra-photoreceptor outer segment separation on spectral domain optical coherence tomography (SD-OCT) in initial-onset acute Vogt-Koyanagi-Harada disease.
    Motegi S; Nagura K; Yoneda K; Harimoto K; Sato T; Herbort CP; Takeuchi M
    Acta Ophthalmol; 2023 May; 101(3):e286-e293. PubMed ID: 36217824
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pseudo-inflammatory manifestations of choroidal lymphoma resembling Vogt-Koyanagi-Harada disease: case report based on multimodal imaging.
    Fukutsu K; Namba K; Iwata D; Mizuuchi K; Kase S; Suzuki K; Shimizu H; Shibata Y; Yamawaki F; Onozawa M; Ishida S
    BMC Ophthalmol; 2020 Mar; 20(1):94. PubMed ID: 32156266
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictive factors and adalimumab efficacy in managing chronic recurrence Vogt-Koyanagi-Harada disease.
    Feng H; Chen W; Yang J; Kong H; Li H; He Y; Wang H
    BMC Ophthalmol; 2024 Jun; 24(1):238. PubMed ID: 38849758
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Role of Widefield Optical Coherence Tomography Angiography in the Diagnosis and Management of Acute Vogt-Koyanagi-Harada Disease.
    Ding X; Shu Q; Bai X; Chang Q; Xu G; Chen L
    Ocul Immunol Inflamm; 2024 May; 32(4):391-401. PubMed ID: 36856749
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Optical coherence tomography in the acute and chronic phases of Vogt-Koyanagi-Harada disease.
    Parc C; Guenoun JM; Dhote R; Brézin A
    Ocul Immunol Inflamm; 2005; 13(2-3):225-7. PubMed ID: 16019683
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Decrease of choriocapillary vascular density measured by optical coherence tomography angiography in Vogt-Koyanagi-Harada disease.
    Liang A; Jia S; Gao F; Han X; Pei M; Qu Y; Xiao J; Zhao C; Zhang M
    Graefes Arch Clin Exp Ophthalmol; 2021 Nov; 259(11):3395-3404. PubMed ID: 34216256
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ultra-wide-field angiography findings in acute Vogt-Koyanagi-Harada disease.
    Kim P; Sun HJ; Ham DI
    Br J Ophthalmol; 2019 Jul; 103(7):942-948. PubMed ID: 30100554
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Autofluorescence combined with spectral domain optical coherence tomography for diagnosis and follow-up of acute Vogt-Koyanagi-Harada disease].
    Tian S; Yao J; Wang J; Zhang J; Zhou A
    Nan Fang Yi Ke Da Xue Xue Bao; 2021 Jan; 41(1):135-140. PubMed ID: 33509766
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.